Accolade (ACCD)
(Delayed Data from NSDQ)
$3.97 USD
-0.22 (-5.25%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $3.97 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Income Statements
Fiscal Year end for Accolade, Inc falls in the month of February .
All items in Millions except EPS data.
2/29/24 | 2/28/23 | 2/28/22 | 2/28/21 | 2/29/20 | |
---|---|---|---|---|---|
Sales | 414 | 363 | 310 | 170 | 133 |
Cost Of Goods | 222 | 199 | 169 | 94 | 74 |
Gross Profit | 192 | 164 | 141 | 77 | 59 |
Selling & Adminstrative & Depr. & Amort Expenses | 307 | 628 | 267 | 123 | 107 |
Income After Depreciation & Amortization | -114 | -464 | -126 | -47 | -48 |
Non-Operating Income | 10 | 0 | 0 | 0 | 0 |
Interest Expense | -6 | 0 | 3 | 4 | 3 |
Pretax Income | -99 | -463 | -129 | -51 | -51 |
Income Taxes | 1 | -4 | -6 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -100 | -460 | -123 | -51 | -51 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -100 | -460 | -123 | -51 | -51 |
Depreciation Footnote | 2/29/24 | 2/28/23 | 2/28/22 | 2/28/21 | 2/29/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -64 | -114 | -80 | -37 | -39 |
Depreciation & Amortization (Cash Flow) | 51 | 350 | 46 | 10 | 10 |
Income After Depreciation & Amortization | -114 | -464 | -126 | -47 | -48 |
Earnings Per Share Data | 2/29/24 | 2/28/23 | 2/28/22 | 2/28/21 | 2/29/20 |
---|---|---|---|---|---|
Average Shares | 74.91 | 71.28 | 63.82 | 29.37 | NA |
Diluted EPS Before Non-Recurring Items | -1.33 | -6.45 | -2.33 | -1.65 | NA |
Diluted Net EPS (GAAP) | -1.33 | -6.45 | -1.93 | -1.72 | NA |
Fiscal Year end for Accolade, Inc falls in the month of February .
All items in Millions except EPS data.
8/31/24 | 5/31/24 | 2/29/24 | 11/30/23 | 8/31/23 | |
---|---|---|---|---|---|
Sales | NA | 110.47 | 124.83 | 99.37 | 96.86 |
Cost Of Goods | NA | 58.61 | 58.19 | 54.52 | 55.32 |
Gross Profit | NA | 51.86 | 66.64 | 44.85 | 41.55 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 80.90 | 74.54 | 76.57 | 76.76 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -29.04 | -7.90 | -31.72 | -35.21 |
Non-Operating Income | NA | 1.79 | -0.49 | 9.28 | 0.75 |
Interest Expense | NA | 0.00 | -1.61 | -1.71 | -1.71 |
Pretax Income | NA | -27.26 | -6.78 | -20.73 | -32.74 |
Income Taxes | NA | 0.34 | 0.73 | 0.33 | 0.08 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -27.59 | -7.51 | -21.06 | -32.83 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -27.59 | -7.51 | -21.06 | -32.83 |
Earnings Per Share Data | 8/31/24 | 5/31/24 | 2/29/24 | 11/30/23 | 8/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 78.12 | 77.35 | 76.14 | 75.49 |
Diluted EPS Before Non-Recurring Items | NA | -0.35 | -0.10 | -0.28 | -0.43 |
Diluted Net EPS (GAAP) | NA | -0.35 | -0.10 | -0.28 | -0.43 |